Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Oral Chinese medicinal composition for treating apoplexia

A technology of composition and traditional Chinese medicine, applied in the direction of drug combination, medical formula, plant raw materials, etc., can solve the problems of low crude drug content, slow onset of action, slow absorption, etc.

Active Publication Date: 2008-12-17
SHANGHAI PHARMA GRP QINGDAO GROWFUL PHARMA CO LTD
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

But it is not difficult to see that the current oral preparations for the treatment of stroke generally have the disadvantages of low crude drug content, slow absorption, and slow onset of action

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0024] Prescription: Astragalus 1333g, Angelica 333g, Chuanxiong 333g, Pueraria 1000g, Cimicifuga 200g, Notopterygium 200g.

[0025] Preparation method: The above six flavors, Angelica, Chuanxiong, and Notopterygium extract the volatile oil, and the obtained volatile oil is encapsulated with an appropriate amount of β-cyclodextrin, and the aqueous solution is collected in a separate device. Combine the dregs with the remaining astragalus and other three flavors, decoct twice, add 9 times of water for the first time, decoct for 1 hour, add 5 times of water for the second time, decoct for 40 minutes, combine the decoction, filter, and concentrate the filtrate to relative density 1.12-1.14 (70°C), let cool, add ethanol until the alcohol content reaches 42.2%, let it stand for 12 hours, filter, recover ethanol from the filtrate, concentrate to a relative density of 1.24-1.26 (70°C), add appropriate amount of auxiliary materials , spray granulation, granulation, add volatile oil in...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

An orally taken Chinese medicine for treating apoplexy is prepared from astragalus root, Chinese angelica root and Chuan-xiong rhizome.

Description

Technical field: [0001] The invention belongs to the technical field of traditional Chinese medicine, and in particular relates to an oral Chinese medicinal composition for treating apoplexy. Background technique [0002] Stroke (cerebrovascular disease) is one of the three major causes of death in humans, characterized by high incidence, high disability rate, high recurrence rate, and high mortality rate. According to relevant statistics, with the change of people's lifestyle, my country has become an area with high incidence of such diseases. At present, there are more than 10 million patients with cerebrovascular diseases in the country, and the death toll is nearly 1 million. There are about 150 new cases every year. Send out this disease, seriously endanger the health and life of mankind. The research on its prevention and treatment has always been a key research topic in the medical field. [0003] Western medicine mostly uses thrombolytic therapy and anticoagulant th...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/71A61K36/481A61K36/48A61K36/237A61K36/236A61K36/232A61P9/10
Inventor 陆鹏黄庆文
Owner SHANGHAI PHARMA GRP QINGDAO GROWFUL PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products